Tirzepatide operates as a dual agonist for GLP-1 and GIP (Glucose-Dependent Insulinotropic Polypeptide) receptors, meaning it mimics and enhances a naturally occurring mechanism in our body
All weight loss products (oral and GLP-1s) are not on formulary but can be accessed if approved through the prior authorization (PA) or non-formulary (NF) exceptions process
These approaches should be discussed with a healthcare professional to ensure they are appropriate for individual circumstances
But you might still qualify if you have the right documented health condition
Both semaglutide and liraglutide were shown to significantly increase weight loss in this patient population due to slower gastric emptying time, increased satiety, decreased hunger and food cravings, as well as alteration of the food reward pathway
Instead of relying on a single pathway, the updated GLP-1 Premium formula is designed to work across the full GLP-1 axis - encouraging natural hormone release, helping maintain its activity, and supporting overall metabolic function
